Financial statements Biopolinex
Balance sheet data of BIOPOLINEX
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 4 267 312,21 | 6 865 240,63 | 7 890 812,68 | 10 545 503,18 | 1 124 483,42 | 9 729 146,12 |
| A. Fixed assets | 715 054,57 | 738 528,52 | 1 127 609,40 | 1 153 526,43 | 1 124 483,42 | 1 114 084,76 |
| B. Current assets | 3 552 257,64 | 6 126 712,11 | 6 763 203,28 | 9 391 976,75 | 7 397 661,66 | 8 615 061,36 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 267 312,21 | 6 865 240,63 | 7 890 812,68 | 10 545 503,18 | 8 522 145,08 | 9 729 146,12 |
| A. Equity | 2 607 892,22 | 3 023 799,74 | 3 158 858,89 | 3 546 286,89 | 2 966 228,26 | 3 085 054,33 |
| B. Liabilities and provisions for liabilities | 1 659 419,99 | 3 841 440,89 | 4 731 953,79 | 6 999 216,29 | 5 555 916,82 | 6 644 091,79 |
| I. Long-term liabilities | 259 087,00 | 430 497,57 | 390 687,85 | 306 511,73 | 215 209,52 | 860 715,79 |
| II. Short-term liabilities | 1 400 332,99 | 3 410 943,32 | 2 991 265,94 | 5 167 704,56 | 3 521 707,30 | 3 964 376,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.